Patents by Inventor Douglass F. Taber

Douglass F. Taber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • -NH- terminated silicon surface and a method for its preparation
    Patent number: 9272914
    Abstract: A uniform Si—NH—Si terminated Si(111) surface is formed by contacting a chlorine-terminated silicon surface with ammonia and a solvent such as an ether.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: March 1, 2016
    Assignee: UNIVERSITY OF DELAWARE
    Inventors: Fangyuan Tian, Douglass F. Taber, Andrew V. Teplyakov
  • AN -NH- TERMINATED SILICON SURFACE AND A METHOD FOR ITS PREPARATION
    Publication number: 20130287667
    Abstract: A uniform Si—NH—Si terminated Si(111) surface is formed by contacting a chlorine-terminated silicon surface with ammonia and a solvent such as an ether.
    Type: Application
    Filed: November 21, 2011
    Publication date: October 31, 2013
    Applicant: University of Delaware
    Inventors: Fangyuan Tian, Douglass F. Taber, Andrew V. Teplyakov
  • Method of making stable, homogeneous potassium hydride dispersions
    Patent number: 8158101
    Abstract: A stable, homogeneous dispersion of potassium hydride is formed by reacting a mixture of wax and potassium metal with hydrogen.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: April 17, 2012
    Assignee: University of Delaware
    Inventors: Douglass F. Taber, Christopher G. Nelson
  • METHOD OF MAKING STABLE, HOMOGENEOUS POTASSIUM HYDRIDE DISPERSIONS
    Publication number: 20100270500
    Abstract: A stable, homogeneous dispersion of potassium hydride is formed by reacting a mixture of wax and potassium metal with hydrogen.
    Type: Application
    Filed: February 4, 2010
    Publication date: October 28, 2010
    Applicant: University of Delaware
    Inventors: Douglass F. Taber, Christopher G. Nelson
  • Treatment of osteoporosis and autoimmune disease with astrogorgiadiol
    Patent number: 7345035
    Abstract: The invention provides methods of downregulating mRNA encoding osteopontin comprising administering to a cell or mammal an amount of astrogorgiadiol effective to downregulate production of mRNA encoding osteopontin. The invention also provides methods of treating osteoporosis and autoimmune disease comprising administering to a patient in need of such treatment a therapeutically effective amount of astrogorgiadiol. Pharmaceutical compositions comprising astrogorgiadiol and a pharmaceutically acceptable carrier or diluent are also provided.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: March 18, 2008
    Assignee: University of Delaware
    Inventors: Douglass F. Taber, Mary C. Farach-Carson, Scott C. Malcolm, Yihuan Xu
  • Treatment of osteoporosis and autoimmune disease with astrogorgiadiol
    Publication number: 20040242677
    Abstract: The invention provides methods of downregulating mRNA encoding osteopontin comprising administering to a cell or mammal an amount of astrogorgiadiol effective to downregulate production of mRNA encoding osteopontin. The invention also provides methods of treating osteoporosis and autoimmune disease comprising administering to a patient in need of such treatment a therapeutically effective amount of astrogorgiadiol. Pharmaceutical compositions comprising astrogorgiadiol and a pharmaceutically acceptable carrier or diluent are also provided.
    Type: Application
    Filed: May 28, 2003
    Publication date: December 2, 2004
    Inventors: Douglass F. Taber, Mary C. Farach-Carson, Scott C. Malcolm, Yihuan Xu